Physician's Weekly

JUNE 18, 2025

WEDNESDAY, June 18, 2025 (HealthDay News) — The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in people with diabetes, according to a study published online June 9 in JAMA Internal Medicine. Pilla, M.D., Pilla, M.D.,

Diabetes 71

Diabetes Internal Medicine Hypertension Clinic 71

Medical Xpress

MAY 8, 2023

GLP1 receptor agonists—a class of diabetes medications—are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease.

Diabetes 98

Diabetes Internal Medicine Medical Patients 98

Physician's Weekly

JUNE 25, 2025

from the Velocity Clinical Research Center at Medical City Dallas, and colleagues conducted a phase 3 trial involving participants with type 2 diabetes treated only with diet and exercise, an HbA1c level of ≥7.0 Mild-to-moderate gastrointestinal events were the most common adverse events with orforglipron. Julio Rosenstock, M.D.,

Diabetes 52

Diabetes Clinic Medical Family Practice 52

Physician's Weekly

JUNE 11, 2025

The most common adverse event reported in patients treated with Widaplik was symptomatic low blood pressure. Widaplik is not to be coadministered with aliskiren in patients with diabetes, and a boxed warning indicates discontinuation of Widaplik during pregnancy.

Hypertension 52

Hypertension Diabetes Patients Medical 52

Physician's Practice

JUNE 23, 2025

Recent Videos Related Content Schrödinger's Cat: Financial perils of Allograft diabetic ulcer grafts Martin Merritt, Esq. June 17th 2025 Article Health care practices face rising audits and recoupments for using placental membrane grafts in diabetic ulcer treatments, risking significant financial penalties.

Consulting 52

Consulting Management Private Practice Diabetes 52

Physician's Practice

JUNE 26, 2025

Schrödinger's Cat: Financial perils of Allograft diabetic ulcer grafts Martin Merritt, Esq. June 17th 2025 Article Health care practices face rising audits and recoupments for using placental membrane grafts in diabetic ulcer treatments, risking significant financial penalties.

Management 52

Management Diabetes Patients Insurance 52

GeriPal

JANUARY 23, 2025

In our third segment, we explore Amy Linskys study that examined the effect of patient-directed educational materials on clinician deprescribing of potentially low-benefit or high-risk medications, such as proton pump inhibitors, high-dose gabapentin, or risky diabetes medications. So insulin, which is the injections, and then sulfonylurea.

Specialization 119

Specialization IT Patient-Centered Medical 119